WGS FY 2025 Earnings — GeneDx Holdings Corp. Revenue & Financial Results | Market Cap Arena

WGSGeneDx Holdings Corp.

$3B

FY 2025 Earnings

Healthcare Medical - Healthcare Information Services

Income Statement

Revenue

$428M+40.0% YoY

Gross Profit

$298M69.7% margin

Operating Income

-$12M-2.8% margin

Net Income

-$21M-4.9% margin

EPS (Diluted)

$-0.73

Cash Flow

Operating Cash Flow

$33M

Free Cash Flow

$14M

Stock-Based Comp.

$32M

Balance Sheet

Total Assets

$570M

Total Liabilities

$262M

Stockholders' Equity

$308M

Cash & Equivalents

$105M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$428M	$305M	+40.0%
Gross Profit	$298M	$194M	+53.4%
Operating Income	-$12M	-$23M	+49.2%
Net Income	-$21M	-$52M	+59.8%